EMP1 and Hepatic fibrosis: Given that HSC activation promotes liver fibrosis and MASLD-IRI enhances fibrosis susceptibility without causing immediate fibrosis (Fig. S2), we next assessed whether EMP1 silencing mitigates fibrosis in a CCl4-induced model.